| (19) |
 |
|
(11) |
EP 0 921 133 B9 |
| (12) |
CORRECTED EUROPEAN PATENT SPECIFICATION |
|
Note: Bibliography reflects the latest situation |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 B1) |
|
Corrections, see Claims |
| (48) |
Corrigendum issued on: |
|
05.07.2006 Bulletin 2006/27 |
| (45) |
Mention of the grant of the patent: |
|
27.07.2005 Bulletin 2005/30 |
| (22) |
Date of filing: 30.11.1998 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (54) |
Manufacture of rubber articles
Herstellung von Gummiartikeln
Fabrication d'articles en caoutchouc
|
| (84) |
Designated Contracting States: |
|
DE FR GB |
| (30) |
Priority: |
03.12.1997 US 984604
|
| (43) |
Date of publication of application: |
|
09.06.1999 Bulletin 1999/23 |
| (60) |
Divisional application: |
|
05011537.7 / 1566391 |
| (73) |
Proprietor: Ansell Healthcare Products Inc. |
|
Massillon,
Ohio 44646 (US) |
|
| (72) |
Inventors: |
|
- Nile, Jeffrey G.
Alliance,
Ohio 44601 (US)
- Gromelski, Stanley J.
Canton,
Ohio 44718 (US)
- Gerber, Nevin D.
New Philadelphia,
Ohio 44601 (US)
|
| (74) |
Representative: Meddle, Alan L. et al |
|
FORRESTER & BOEHMERT,
Pettenkoferstrasse 20-22 80336 München 80336 München (DE) |
| (56) |
References cited: :
EP-A- 0 640 623 WO-A-96/25279
|
WO-A-96/23643
|
|
| |
|
|
- DATABASE WPI Section Ch, Week 8451 Derwent Publications Ltd., London, GB; Class A12,
AN 84-316346 XP002094955 & JP 59 199701 A (TERUMO CORP) , 12 November 1984
|
|
| |
|
| Note: Within nine months from the publication of the mention of the grant of the European
patent, any person may give notice to the European Patent Office of opposition to
the European patent
granted. Notice of opposition shall be filed in a written reasoned statement. It shall
not be deemed to
have been filed until the opposition fee has been paid. (Art. 99(1) European Patent
Convention).
|
[0001] This is a continuation-in-part of application Serial No. 08/847,323, filed April
23, 1997, which is pending.
Field of the Invention
[0002] This invention relates to powder-free rubber articles produced by latex dipping and
to the methods and materials used in their manufacture. More particularly, the invention
relates to the production of powder-free natural and synthetic rubber latex medical
articles, such as surgical and medical gloves, condoms and catheters, by employing
a powder-free coagulant during fabrication.
Background of the Invention
[0003] The manufacture of a typical latex surgical glove generally requires latex and powders,
as well as water, vulcanizing agents, accelerators, activators, blockers, retarders,
antioxidants, preservatives, odorants, colorants, stabilizers, and other processing
aids. The powder serves two important functions in the manufacture and use of latex
gloves and other products -- it facilitates the release of a glove from a glove former
during manufacture and it aids the donning of the gloves during use.
[0004] Gloves are manufactured by dipping ceramic or aluminum glove formers shaped like
hands into tanks of liquid latex and admixed chemicals. The formers are precoated
with a coagulant to gel the latex and to facilitate the subsequent removal of the
glove from the former. The precoated formers are then dipped in the tanks of chemicals
necessary to make the gloves. The "wet" gloves are dried and cured in a heated oven
and the latex glove cures on the mold. The outside layer of the dipped former will
ultimately be the inside of the glove . While still on the formers, the latex gloves
also go through one or more rinses to leach out proteins and residual chemicals before
they are stripped off the mold, packaged, and sterilized. The latex contains vulcanization
agents that cure the natural rubber and produce a dry rubber film. Thus, the film
surface of the cured natural rubber is quite "tacky" after the glove is dried. It
is therefore necessary to incorporate detackifying powders in the manufacturing process
to facilitate the release of a glove from its glove former. Powders are also used
to aid the donning of the gloves.
[0005] The use of powder complicates the manufacturing process and may cause respiratory
problems for workers during the manufacturing process. Likewise, powder can be released
into the air and inhaled when medical or health care personnel don and remove their
gloves during subsequent use.
[0006] In order to reduce the likelihood of such problems, it is common practice for health
care personnel to remove excess powder from the gloves after donning by wiping gloves
thoroughly with a sterile sponge or sterile towel. Similarly, manufacturers attempt
to minimize the amount of powder on the gloves they manufacture by including additional
manufacturing steps in the glove fabrication process. For example, some manufacturers
subject the fabricated gloves to air-blowing or tumbling operations to remove excess
powder. Other processes include encapsulation of the powder in the gloves by dipping
the formed glove in a laminate material having better donning properties than the
base rubber. Yet other processes halogenate the formed gloves to remove the powder
and create a smooth glove surface.
[0007] Each of the foregoing processes reduce, but do not eliminate, the problems associated
with the use of powdered gloves. As a result, one process completely eliminates the
use of powder. U.S. Patent No. 4,543,844 to Podell et al. discloses a powder-free
article made by conventional dipping techniques. However, Podell et al. eliminates
the use of powder only by using a manufacturing process substantially more complex
than that of the prior art. Whereas the prior art rendered glove surfaces tack-free
by washing the finished gloves in a slurry of powder, Podell et al. achieved a powder-free
glove only by washing the finished glove (i.e., after removal from the former) in
a surfactant or an emulsion such as an aqueous silicone solution, and drying the washed
glove in a heated oven prior to a final rinse in water. Moreover, the surfactant or
emulsion was effective to eliminate tack only if further steps, such as dipping the
former in acid and a hydrophilic polymer, were taken prior to vulcanizing the glove
and removing it from the formers. Thus, Podell et al. does not render the manufactured
glove tack-free until after the glove is removed from the former on which it is made.
[0008] Because powder is used in glove manufacturing processes in order to facilitate removal
of the gloves from the glove formers, such powder-free gloves are difficult to remove
from their formers because they are tacky. The process required to strip such gloves
is much more complicated or labor intensive and also more time consuming than it would
be if the gloves on the formers were tack-free. For example, because the gloves manufactured
according to Podell et al. were still tacky while on the formers, they had to be removed
from their formers by manual labor. Many gloves are lost because they stick to the
formers and are damaged during the removal process. It is therefore desirable to have
a powder-free, tack-free glove that has good donning properties, that can be easily
stripped from the glove formers following fabrication and that can be manufactured
with a minimum number of processing steps.
[0009] The present invention solves the foregoing problems by providing a powder-free glove
that is readily removable from the glove former following glove fabrication. The present
invention also provides a powder-free coagulant and a glove fabrication process that
includes that powder-free coagulant.
Summary of the Invention
[0010] Accordingly, it is an object of the present invention to provide powder-free rubber
articles produced by latex dipping.
[0011] It is another object of the present invention to provide a powder-free glove that
can be easily stripped from the glove formers following fabrication.
[0012] A further object of the present invention is to provide such powder-free rubber articles
that are durable and provide cut and abrasion protection.
[0013] The foregoing and additional objects are realized in the present invention that provides
a powder-free coagulant composition for natural and synthetic rubber latex in accordance
with Claim 1.
[0014] In embodiments of the present invention, the coagulant composition may be employed
in combination with a surfactant and a cationic surface active agent.
[0015] In another aspect of the present invention, there is provided a process for fabricating
a powder-free, tack-free, silicone-free rubber article in accordance with Claim 10.
[0016] Articles produced in accordance with the invention include those produced by conventional
latex dipping processes, such as medical and surgical gloves, condoms and catheters.
[0017] Other features, objects and advantages of the present invention will become apparent
from the following detailed description and claims.
Detailed Description of the Invention
[0018] According to the present invention, various articles, and in particular gloves, may
be manufactured using a variety of different techniques. According to a preferred
embodiment, the gloves are produced in a mass production line where a great plurality
of gloves are sequentially, rapidly and consistently produced. Such a technique conveys
and manipulates multiple glove formers through a series of chemical solutions that
make the glove. The formers are made of porcelain, steel or plastic. According to
the standard manufacturing process, gloves may be produced directly on the formers
that are conveyed from one station to the next. For example, the formers are dipped
into surfactants, waxes, coagulants and natural or synthetic resins to obtain a layer
of the desired characteristics. The formers can also be overdipped with a silicone
emulsion. The technique allows for altering the composition, the order of application,
and the method of application of ingredients that make up the layer of the glove.
In addition, specific characteristics of the material, such as breathability, moisture
absorbency, thickness, tensile strength, penetration resistance, stretch characteristics,
flexibility and density of the finished product, may be controlled.
[0019] The glove may be built up from multiple dips into various substances. For example,
the formers may be initially dipped into a composition of a powder free release agent
and a coagulant. That release agent and coagulant dip supplies a release material
for the subsequent removal of the finished glove from the formers. In addition, the
coagulant material will destabilize subsequent liquid resin materials such as elastomers.
[0020] Alternatively the former may be first treated with a powder-free release agent and
then with a coagulant. Separate applications of the powder-free release agent and
coagulant may necessitate a long drying period between and after their application.
Such long drying times are costly as they require modifications to a continuous dipping
line. The two step method of treating the formers also requires greater temperatures
than that of the one step process. As a result, more complicated parameter control
is required and cost is increased. But, the mixture of coagulant and release agent
for use in a single dipping step does not exhibit the degree of instability that would
normally be expected due to the differing chemical characteristics of the constituents
used in compounding the powder-free coagulant.
[0021] After the release agent/coagulant dip is applied, the formers are preferably conveyed
to the next station in the production line where the laminate layer is applied to
the formers. The laminate layer may be comprised of an elastomeric or liquid resin
dip, such as natural rubber latex. Alternatively, the laminate layer may be a natural
or synthetic rubber, such as synthetic latex, polyurethane, nitrile or polychloroprene.
By varying the content of the latex material, the laminate layer may be varied to
provide different degrees of strength, comfort and flexibility. In any event, the
content of the latex applied to the former will preferably be adjusted to provide
the desired gripability, protection from cuts and abrasions and liquid repellency.
If desired, the gelled latex film can be overdipped with copolymers of vinyl methyl
ether and maleic esters.
[0022] After the application of the laminate layer, a second coagulant dip may be applied
if another laminate layer is to be applied. The second coagulant dip, which is preferably
in the form of a tackifying agent, provides a medium for adherence of the laminate
applied in the next step. According to an alternative technique, the formers may be
immersed into an adhesive dip to provide strength and a tacky surface for the application
of the next laminate layer. Such an adhesive dip may be comprised of any synthetic
resin material, and preferably an elastomer. Different degrees of strength and flexibility
may be obtained by varying the characteristics of the adhesive material. After application
of either a second coagulant dip or an adhesive dip, the formers are conveyed to the
next station where the next laminate layer is applied.
[0023] After application of one or more laminate layers, the formers are preferably passed
through ovens at elevated temperatures to dry and cure and provide the final product.
The gloves are then removed either manually or by an automated technique.
[0024] According to the substantially automated mass production technique described above,
a great number of variations may be introduced to provide additional or different
desired characteristics of the laminate in accordance with the present invention.
[0025] The preferred embodiment of the powder-free coagulant dip is a formulation including
a coagulant mixed with water, a surfactant, a detackification agent, an aqueous polychloroprene
and an accelerator. That embodiment permits the different functions of the discrete
components to be performed in a single dipping step rather than multiple dipping steps.
[0026] According to the present invention, the coagulating solution includes an aqueous
solution of a divalent cationic metal salt and a salt stable polymer. Preferably,
the salt is calcium nitrate and the calcium nitrate content is between 7% and 50%
by weight of the total coagulant content. More preferably, the calcium nitrate content
is in a range of 30% to 45% of the total coagulant content. The coagulating agent
most preferably comprises aqueous based calcium nitrate having a solids content of
60% to 70% by weight of the raw material. Other divalent cationic metals salts such
as, for example, calcium chloride, zinc nitrate, zinc chloride, magnesium acetate,
magnesium nitrate, aluminum nitrate and aluminum sulphate may be used individually
or in combination with the calcium nitrate.
[0027] The salt stable polymer dispersion employed in the present invention is preferably
a salt-stable and electrolyte-stable polychloroprene dispersion. Suitable polychloroprenes
include those sold under the trade name Neoprene. The preferred embodiment in accordance
with the present invention includes Neoprene 115, having a raw material solids content
of about 46%. Preferably, the quantity of polychloroprene in the coagulant of the
present invention is between 1% and 20% by weight of the coagulant. More preferably,
the polychloroprene content is between 1% and 8% of the total coagulant content. Of
course, other salt stable dispersions, such as, for example, polyurethenes available
from Witco Corp., 6200 W. 51st Street, Chicago, Illinois, under the trade designations
YA127-71 and YA127-79, may also be used in accordance with the invention.
[0028] A cross-linking agent to cure the salt stable polymer may also be added. Suitable
cross-linking agents include dicarboxylic and tricarboxylic acids, polyamide resins
and melamine formaldehyde resins. Preferably, the cross-linking agent is present in
an amount between 3% and 15% by weight of the polychloroprene and more preferably,
between 5% and 10% by weight of the polychloroprene.
[0029] The presence of a surfactant, or surface active agent, in the coagulant composition
increases the stability of the dispersion. The surfactant also provides advantageous
coagulant film forming properties because it has a greater affinity for the former
than it does for the chloroprene in the dispersion. As a result, the surfactant acts
as a mould release between the former and the chloroprene and thereby facilitates
removal of the formed article from the former without the need for or use of powders
or release agents such as silicone. In accordance with a preferred embodiment of the
invention, the coagulant solution contains an amphoteric surfactant present in amounts
of between 0.5% and 15% by weight of the composition. Preferably, surface active agents
are present in amounts of from 1% to 10% by weight of the composition. According to
the present invention, the preferred surfactant is a cationic surface active agent
available from Mona Industries, 76 E. 24th Street, Patterson, New Jersey, under the
trade name Phospholipid PT-L, however, other quaternary surfactants, amphoteric surfactants,
triquaternary phosphate esters and betaine derivatives may be used.
[0030] Likewise, the inclusion in the coagulant solution of wax compound aids in detackification
and release of the formed article from the former. Detackification agents suitable
for use in accordance with the present invention include low and high density homopolymers
and copolymers, microcrystalline waxes, castor waxes, long chain fatty esters, paraffin
wax, bees wax and polyamide wax.
1. A powder-free coagulant composition for natural and synthetic rubber latex wherein
the coagulant composition comprises an aqueous, salt stable polymer dispersion, at
least one inorganic metal salt and a detackification agent selected from the group
consisting of a microcrystalline wax, a castor wax, a long chain fatty ester, a paraffin
wax, a bees wax and a polyamide wax.
2. A powder-free coagulant composition according to Claim 1 further comprising a surfactant.
3. A powder-free coagulant composition according to Claim 1 further comprising a cross-linking
agent to cure the salt stable polymer.
4. A powder-free coagulant composition according to Claim 1 wherein the aqueous, salt
stable polymer is selected from the group consisting essentially of polychloroprenes,
polyurethanes and mixtures thereof and further wherein the aqueous, salt stable polymer
is present in an amount between 1% and 20% by weight of the coagulant composition.
5. A powder-free coagulant composition according to Claim 1 wherein the at least one
inorganic metal salt is a divalent cationic metal salt and further wherein the at
least one inorganic metal salt is present in an amount between 7% and 50% by weight
of the coagulant composition.
6. A powder-free coagulant composition according to Claim 5 wherein the at least one
inorganic metal salt is selected from the group consisting essentially of calcium
nitrate, calcium chloride, zinc nitrate, zinc chloride, magnesium acetate, magnesium
nitrate, aluminum nitrate and aluminum sulphate and mixtures thereof.
7. A powder-free coagulant composition according to Claim 3 wherein the cross-linking
agent is selected from the group consisting essentially of aqueous based dicarboxylic
and tricarboxylic acids, polyamide resins, melamine formaldehyde resins and mixtures
thereof and further wherein the cross-linking agent is present in an amount between
3% and 15% by weight of the coagulant composition.
8. A powder-free coagulant composition according to Claim 2 wherein the surfactant is
selected from the group consisting essentially of quaternary surfactants, amphoteric
surfactants, triquaternary phosphate esters, betaine derivatives and mixtures thereof
and further wherein the surfactant is present in an amount between 0.5% and 15% by
weight of the coagulant composition.
9. A process for fabricating a powder-free, tack-free rubber article which comprises:
a. dipping a shaped, pre-heated former into an aqueous, powder-free solution which
solution comprises an aqueous, salt stable polychloroprene dispersion, an inorganic
metal salt and a detackification agent selected from the group consisting of a microcystalline
wax, a castor wax, a long chain fatty ester, a paraffin wax, a bees wax and a polyamide
wax;
b. dipping the former in a solution of natural rubber latex to form a gelled latex
film to create a tack-free surface for the article;
c. leaching the gelled latex film, curing the formed rubber article on the former
and dry stripping the cured tack-free article from the former
10. A process according to Claim 9 wherein the aqueous, powder-free solution further comprises
a cross-linking agent selected from the group consisting essentially of aqueous based
dicarboxylic and tricarboxylic acids, polyamide resins, melamine formaldehyde resins
and mixtures thereof and further wherein the cross-linking agent is present in an
amount between 3% and 15% by weight of the coagulant composition.
11. A process according to Claim 9 wherein the aqueous, powder-free solution further comprises
a surfactant selected from the group consisting essentially of quaternary surfactants,
amphoteric surfactants, triquaternary phosphate esters, betaine derivatives and mixtures
thereof and further wherein the surfactant is present in an amount between 0.5% and
15% by weight of the coagulant composition.
12. An article of manufacture made using the process of Claim 9.
13. An article of Claim 12 wherein the article is a glove.
14. The article of Claim 12 wherein the article is a condom.
15. An article of manufacture made using the powder-free coagulant composition of Claim
1.
16. A process according to Claim 9, wherein the polychloroprene content is in a range
of 1% to 20% of the total coagulant content.
17. A process according to Claim 9, in which the inorganic salt is an aqueous solution
of calcium nitrate.
18. A process according to Claim 17, in which the calcium nitrate content is in a range
of 7% to 50% of the composition.
19. A process according to Claim 9, in which a cross-linking agent is added to cure the
salt stable polymer dispersion.
20. A process according to Claim 9, wherein the aqueous powder-free solution further comprises
a cationic surface active agent.
21. A method according to Claim 9 further comprising the step of overdipping the gelled
latex film produced in step c) with copolymers of vinyl methyl ether and maleic esters.
22. A method according to Claim 9 further comprising the step of overdipping the former
with a silicone emulsion.
23. A dipped rubber article made in accordance with the method of Claim 9, wherein said
article comprises a medical glove.
1. Pulverfreie Koagulatorzusammensetzung für Natur- und Synthesekautschuklatex, wobei
die Koagulatorzusammensetzung eine wäßrige, salzstabile Polymerdispersion, wenigstens
ein anorganisches Metallsalz und ein Entklebungsagens ausgewählt aus der Gruppe bestehend
aus einem mikrokristallinen Wachs, einem Castorwachs, einem langkettigen Fettester,
einem Paraffinwachs, einem Bienewachs und einem Polyamidwachs umfaßt.
2. Pulverfreie Koagulatorzusammensetzung nach Anspruch 1, welche weiter ein oberflächenaktives
Mittel umfaßt.
3. Pulverfreie Koagulatorzusammensetzung nach Anspruch 1, welche weiter ein Vernetzungsmittel
umfaßt, um das salzstabile Polymer auszuhärten.
4. Pulverfreie Koagulatorzusammensetzung nach Anspruch 1, wobei das wäßrige, salzstabile
Polymer ausgewählt ist aus der Gruppe, die im wesentlichen aus Polychloroprenen, Polyurethanen
und Mischungen derselben besteht, und wobei weiter das wäßrige, salzstabile Polymer
in einer Menge zwischen 1 Gew.-% und 20 Gewichtsprozent der Koagulatorzusammensetzung
vorliegt.
5. Pulverfreie Koagulatorzusammensetzung nach Anspruch 1, wobei das wenigstens eine anorganische
Metallsalz ein zweiwertiges kationisches Metallsalz ist, und wobei weiter das wenigstens
eine anorganische Metallsalz in einer Menge zwischen 7 Gew.-% und 50 Gewichtsprozent
der Koagulatorzusammensetzung vorliegt.
6. Pulverfreie Koagulatorzusammensetzung nach Anspruch 5, wobei das wenigstens eine anorganische
Metallsalz ausgewählt ist aus der Gruppe, die im wesentlichen aus Calciumnitrat, Calciumchlorid,
Zinknitrat, Zinkchlorid, Magnesiumacetat, Magnesiumnitrat, Aluminiumnitrat und Aluminiumsulfat
und Mischungen derselben besteht.
7. Pulverfreie Koagulatorzusammensetzung nach Anspruch 3, wobei das Vernetzungsmittel
ausgewählt ist aus der Gruppe, die im wesentlichen aus auf Wasser basierten Dicarboxyl-
und Tricarboxylsäuren, Polyamidharzen, Melaminformaldehydharzen und Mischungen derselben
besteht, und wobei weiter das Vernetzungsmittel in einer Menge zwischen 3 Gew.-% und
15 Gew.-% der Koagulatorzusammensetzung vorliegt.
8. Pulverfreie Koagulatorzusammensetzung nach Anspruch 2, wobei das oberflächenaktive
Mittel ausgewählt ist aus der Gruppe, die im wesentlichen aus quartären oberflächenaktiven
Mitteln, amphoteren oberflächenaktiven Mitteln, triquartären Phosphatestern, Betainderivaten
und Mischungen derselben besteht, und wobei weiter das oberflächenaktive Mittel in
einer Menge zwischen 0,5 Gew.-% und 15 Gew.-% der Koagulatorzusammensetzung vorliegt.
9. Verfahren zum Herstellen eines pulverfreien, klebfreien Kautschukgegenstands, welches
umfaßt:
a. Eintauchen einer geformten, vorgeheizten Tauchform in eine wäßrige, pulverfreie
Lösung, wobei die Lösung eine wäßrige, salzstabile Polychloroprendispersion, ein anorganisches
Metallsalz und ein Entklebungsagens ausgewählt aus der Gruppe bestehend aus einem
mikrokristallinen Wachs, einem Castorwachs, einem langkettigen Fettester, einem Paraffinwachs,
einem Bienewachs und einem Polyamidwachs umfaßt;
b. Eintauchen der Tauchform in eine Lösung von Naturkautschuklatex, um einen erstarrten
Latexfilm zu bilden, um eine klebfreie Oberfläche für den Gegenstand zu schaffen;
c. Herauslösen des erstarrten Latexfilms, Aushärten des gebildeten Kautschukgegenstands
auf der Tauchform und Trockenabziehen des ausgehärteten klebfreien Gegenstands von
der Tauchform.
10. Verfahren nach Anspruch 9, wobei die wäßrige, klebfreie Lösung ferner ein Vernetzungsmittel
umfaßt, das ausgewählt wird aus der Gruppe, die im wesentlichen aus auf Wasser basierenden
Dicarboxyl- und Tricarboxylsäuren, Polyamidharzen, Melaminformaldehydharzen und Mischungen
derselben besteht, und wobei weiter das Vernetzungsmittel in einer Menge zwischen
3 Gew.-% und 15 Gew.-% der Koagulatorzusammensetzung vorliegt.
11. Verfahren nach Anspruch 9, wobei die wäßrige, pulverfreie Lösung ferner ein oberflächenaktives
Mittel umfaßt, das ausgewählt wird aus der Gruppe, die im wesentlichen aus quartären
oberflächenaktiven Mitteln, amphoteren oberflächenaktiven Mitteln, triquartären Phosphatestern,
Betainderivaten und Mischungen derselben besteht, und wobei das oberflächenaktive
Mittel weiter in einer Menge zwischen 0,5 Gew.-% und 15 Gew.% der Koagulatorzusammensetzung
vorliegt.
12. Herstellungsgegenstand, hergestellt unter Verwendung des Verfahrens nach Anspruch
9.
13. Gegenstand nach Anspruch 12, wobei der Gegenstand ein Handschuh ist.
14. Gegenstand nach Anspruch 12, wobei der Gegenstand ein Kondom ist.
15. Herstellungsgegenstand, hergestellt unter Verwendung der pulverfreien Koagulatorzusammensetzung
nach Anspruch 1.
16. Verfahren nach Anspruch 9, wobei der Polychloroprengehalt in einem Bereich von 1 %
bis 20% des gesamten Koagulatorgehalts liegt.
17. Verfahren nach Anspruch 9, bei dem das anorganische Salz eine wäßrige Lösung von Calciumnitrat
ist.
18. Verfahren nach Anspruch 17, bei dem der Calciumnitratgehalt in einem Bereich von 7%
bis 50% der Zusammensetzung liegt.
19. Verfahren nach Anspruch 9, bei welchem ein Vernetzungsmittel zugefügt wird, um die
salzstabile Polymerdispersion auszahärten.
20. Verfahren nach Anspruch 9, wobei die wäßrige pulverfreie Lösung ferner ein kationisches
oberflächenaktives Mittel umfaßt.
21. Verfahren nach Anspruch 9, weiter umfassend den Schritt eines Übertauchens des erstarrten
Latexfilms, der in Schritt c) hergestellt worden ist, mit Copolymeren von Vinylmethylether
und Maleinsäureestern.
22. Verfahren nach Anspruch 9, weiter umfassend den Schritt eines Übertauchens der Tauchform
mit einer Silikonemulsion.
23. Eingetauchter Kautschukgegenstand, hergestellt gemäß dem Verfahren von Anspruch 9,
wobei der Gegenstand einen Medizinhandschuh umfaßt.
1. Composition de coagulant sans poudre pour latex en caoutchouc naturel et synthétique,
dans laquelle la composition de coagulant comprend une dispersion aqueuse de polymère
stable en sel, au moins un sel métallique inorganique et un agent de décollement choisi
dans le groupe constitué par une cire microcristalline, une cire de ricin, un ester
gras à longue chaîne, une cire de paraffine, une cire d'abeille et une cire de polyamide.
2. Composition de coagulant sans poudre selon la Revendication 1, comprenant en outre
un agent tensioactif.
3. Composition de coagulant sans poudre selon la Revendication 1, comprenant en outre
un agent de réticulation destiné à durcir le polymère stable en sel.
4. Composition de coagulant sans poudre selon la Revendication 1, dans laquelle le polymère
aqueux stable en sel est choisi dans le groupe constitué essentiellement par les polychloroprènes,
les polyuréthanes et les mélanges de ceux-ci et dans laquelle en outre le polymère
aqueux stable en sel est présent en une quantité comprise entre 1% et 20% en poids
de la composition de coagulant.
5. Composition de coagulant sans poudre selon la Revendication 1, dans laquelle le au
moins un sel métallique inorganique est un sel métallique cationique divalent et dans
laquelle en outre le au moins un sel métallique inorganique est présent en une quantité
comprise entre 7% et 50% en poids de la composition de coagulant.
6. Composition de coagulant sans poudre selon la Revendication- 5, dans laquelle le au
moins un sel métallique inorganique est choisi dans le groupe constitué essentiellement
par le nitrate de calcium, le chlorure de calcium, le nitrate de zinc, le chlorure
de zinc, l'acétate de magnésium, le nitrate de magnésium, le nitrate d'aluminium,
le sulfate d'aluminium et les mélanges de ceux-ci.
7. Composition de coagulant sans poudre selon la Revendication 3, dans laquelle l'agent
de réticulation est choisi dans le groupe constitué essentiellement par les acides
dicarboxyliques et tricarboxyliques à base aqueuse, les résines de polyamide, les
résines de mélamine formaldéhyde et les mélanges de ceux-ci et dans laquelle en outre
l'agent de réticulation est présent en une quantité comprise entre 3% et 15% en poids
de la composition de coagulant.
8. Composition de coagulant sans poudre selon la Revendication 2, dans laquelle l'agent
tensioactif est choisi dans le groupe constitué essentiellement par les agents tensioactifs
quaternaires, les agents tensioactifs amphotères, les esters phosphates triquaternaires,
les dérivés de bétaïne et les mélanges de ceux-ci et dans laquelle en outre l'agent
tensioactif est présent en une quantité comprise entre 0,5% et 15% en poids de la
composition de coagulant.
9. Procédé de fabrication d'un article en caoutchouc sans poudre sans collant, qui comprend
:
a. l'immersion d'un gabarit conformateur préchauffé façonné dans une solution aqueuse
sans poudre laquelle solution comprend une dispersion aqueuse de polychloroprène stable
en sel, un sel métallique inorganique et un agent de décollement choisi dans le groupe
constitué par une cire microcristalline, une cire de ricin, un ester gras à longue
chaîne, une cire de paraffine, une cire d'abeille et une cire de polyamide ;
b. l'immersion du gabarit conformateur dans une solution de latex en caoutchouc naturel
pour former un film en latex gélifié pour créer une surface sans collant pour l'article
;
c. le lessivage du film en latex gélifié, le durcissement de l'article en caoutchouc
formé sur le gabarit conformateur et le retrait à sec de l'article sans collant durci
du gabarit conformateur.
10. Procédé selon la Revendication 9, selon lequel la solution aqueuse sans poudre comprend
en outre un agent de réticulation choisi dans le groupe constitué essentiellement
par les acides dicarboxyliques et tricarboxyliques à base aqueuse, les résines de
polyamide, les résines de mélamine formaldéhyde et les mélanges de ceux-ci et selon
lequel en outre l'agent de réticulation est présent en une quantité comprise entre
3% et 15% en poids de la composition de coagulant.
11. Procédé selon la Revendication 9, selon lequel la solution aqueuse sans poudre comprend
en outre un agent tensioactif choisi dans le groupe constitué essentiellement par
les agents tensioactifs quaternaires, les agents tensioactifs amphotères, les esters
phosphates triquaternaires, les dérivés de bétaïne et les mélanges de ceux-ci et selon
lequel en outre l'agent tensioactif est présent en une quantité comprise entre 0,5%
et 15% en poids de la composition de coagulant.
12. Article de manufacture produit en utilisant le procédé de la Revendication 9.
13. Article selon la Revendication 12, selon lequel l'article est un gant.
14. Article selon la Revendication 12, selon lequel l'article est un préservatif.
15. Article de manufacture fabriqué en utilisant la composition de coagulant sans poudre
de la Revendication 1.
16. Procédé selon la Revendication 9, selon lequel la teneur en polychloroprène est dans
une gamme de 1% à 20% de la teneur totale en coagulant.
17. Procédé selon la Revendication 9, selon lequel le sel inorganique est une solution
aqueuse de nitrate de calcium.
18. Procédé selon la Revendication 17, selon lequel la teneur en nitrate de calcium est
dans une gamme de 7% à 50% de la composition.
19. Procédé selon la Revendication 9, selon lequel un agent de réticulation est ajouté
pour durcir la dispersion de polymère stable en sel.
20. Procédé selon la Revendication 9, selon lequel la solution aqueuse sans poudre comprend
en outre un agent tensioactif cationique.
21. Procédé selon la Revendication 9, comprenant en outre l'étape de surimmersion du film
en latex gélifié produit à l'étape c) avec des copolymères de vinyl méthyl éther et
d'esters maléiques.
22. Procédé selon la Revendication 9, comprenant en outre l'étape de surimmersion du gabarit
conformateur avec une émulsion de silicone.
23. Article en caoutchouc immergé produit selon le procédé de la Revendication 9, selon
lequel ledit article comprend un gant médical.